FDA-approved labeling for some buprenorphine products recommend avoiding vardenafil hydrochloride prescription drug on line with Class 1A and Class III antiarrhythmic medications while other labels recommend avoiding use with any drug that has the potential to prolong the QT interval, such as vardenafil. Keep out of the reach of children. Oral dosage oral tablet; e.
Coadministration of indinavir mg every vardenafil hydrochloride prescription drug on line hours with a single dose of vardenafil 10 mg altered the pharmacokinetics of vardenafil with a fold increase in AUC, a 7-fold increase in Cmax, and a 2-fold increase in half-life. Major Because both risperidone and vardenafil have been associated with a possible risk for QT prolongation and torsade de pointes TdPcautious methotrexate prescription is recommended. Due to the extremely long half-life of amiodarone, a drug interaction is possible for days to weeks after discontinuation of amiodarone. For males 65 years of age or older, consider vardenafil hydrochloride prescription drug on line lower starting dose of 5 mg PO.
See also:
Anteros
Coadministration could lead to the risk of additive QT prolongation. Major It may be prudent to avoid the use of vardenafil in patients being treated with erythromycin. Therapeutic 10 mg and supratherapeutic 80 mg doses of vardenafil also vardenafil hydrochloride prescription drug on line an increase in QTc interval e. Adult males taking erythromycin, ketoconazole mg daily, or itraconazole mg daily. Although there are no studies examining the effects of dronedarone in patients receiving other QT prolonging drugs, coadministration of such drugs may result in additive QT prolongation.
The physiologic mechanism of erection of the penis involves release of nitric oxide NO in the vardenafil hydrochloride prescription drug on line cavernosum during sexual stimulation. Major Case reports indicate that QT prolongation and torsade de pointes TdP can occur during donepezil therapy. Dronedarone administration is associated with a dose-related increase in the QTc interval.
Initial vardenafil dose: Carbetapentane; Guaifenesin; Phenylephrine: Additionally, posaconazole has been associated with prolongation of the QT interval as well as rare cases of TdP; avoid use with other drugs that may prolong the QT interval and are metabolized through CYP3A4, such as vardenafil.
Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include degarelix. Artemether; Lumefantrine: Guaifenesin; Phenylephrine:
Back to top. The effects of these drugs on the QT interval should be considered when prescribing the drug.